Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritonavir and Lopinavir in recurrent high-grade glioma
NCT01095094Phase 2Terminated
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ritonavir, lopinavir in glioma, sponsored by Case Comprehensive Cancer Center. Started Jan 2009; status: terminated.
02
Drugs
ritonavirlopinavir
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01095094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095094.